在COVID-19和疫苗诱导的血小板-中性粒细胞相互作用的血小板性血小板性血小板缺血症
Johannes Hirsch1,2, Günalp Uzun1,2, Jan Zlamal1,2
1Institute of Clinical and Experimental Transfusion Medicine, University Hospital of Tuebingen, Tuebingen, Germany.
Frontiers in immunology
|June 5, 2023
概括
本综述探讨了COVID-19相关的凝血病 (CAC) 和疫苗诱导的血栓性血栓性缺血症 (VITT) 中血小板和中性粒细胞之间的复杂相互作用. 了解这种相互作用对于管理这些血栓性疾病至关重要.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- COVID-19通常会导致血栓性透析,称为COVID-19相关的凝血病 (CAC).
- CAC的病理生理学涉及过度活化的血小板和中性粒细胞外细胞陷 (NETs).
- 疫苗诱导的血栓性血栓细胞衰减 (VITT) 是一种罕见的,严重的自身免疫性疾病,与腺病毒载体疫苗有关.
研究的目的:
- 总结有关COVID-19中血小板-中性粒细胞相互作用的当前知识.
- 审查血小板-中性粒细胞相互作用在VITT病理生理学中的作用.
- 突出了解这些相互作用对于患者管理和VITT预防的重要性.
主要方法:
- 关于COVID-19凝血病现有研究的文献综述.
- 对VITT及其自身免疫机制的研究分析.
- 结合了有关血小板与中性粒细胞在血栓事件中的交叉结合的研究结果.
主要成果:
- 血小板和中性粒细胞的激活是导致COVID-19相关的凝血病的关键因素.
- 在CAC中血小板和中性粒细胞之间的双向关系需要进一步研究.
- 了解VITT血栓友正在演变,对治疗有潜在的影响.
结论:
- 血小板与中性粒细胞的相互作用对COVID-19和VITT的血栓性并发症至关重要.
- 对这种交叉通话的进一步研究可能会揭示新的治疗点.
- 更好的理解可以帮助管理患有这些严重疾病的患者.
相关概念视频
Formation of the Platelet Plug
6.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
569
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
569
Structure and Function of Platelets
1.3K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
767
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
767


